Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
主要作者: | Hoque, Ismoth Ara |
---|---|
其他作者: | Azam, Faruque |
格式: | Thesis |
語言: | English |
出版: |
Brac University
2024
|
主題: | |
在線閱讀: | http://hdl.handle.net/10361/23164 |
相似書籍
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
由: Paul, Pulock
出版: (2024) -
Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
由: Rahman, Tasnim
出版: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Karim, Samia Binte
出版: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
由: Flora, Sanzida Alam
出版: (2024) -
Molecules associated with the development of lung cancer
由: Rahman, Adree, et al.
出版: (2023)